These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29150062)

  • 21. Cesarean section and rate of subsequent stillbirth, miscarriage, and ectopic pregnancy: a Danish register-based cohort study.
    O'Neill SM; Agerbo E; Kenny LC; Henriksen TB; Kearney PM; Greene RA; Mortensen PB; Khashan AS
    PLoS Med; 2014 Jul; 11(7):e1001670. PubMed ID: 24983970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study.
    Mascolo A; di Mauro G; Fraenza F; Gaio M; Zinzi A; Pentella C; Rossi F; Capuano A; Sportiello L
    Front Immunol; 2022; 13():965171. PubMed ID: 36263025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    Rüggeberg JU; Gold MS; Bayas JM; Blum MD; Bonhoeffer J; Friedlander S; de Souza Brito G; Heininger U; Imoukhuede B; Khamesipour A; Erlewyn-Lajeunesse M; Martin S; Mäkelä M; Nell P; Pool V; Simpson N;
    Vaccine; 2007 Aug; 25(31):5675-84. PubMed ID: 17448577
    [No Abstract]   [Full Text] [Related]  

  • 24. Trends in ectopic pregnancy, hydatidiform mole and miscarriage in the largest obstetrics and gynaecology hospital in China from 2003 to 2013.
    Li XL; Du DF; Chen SJ; Zheng SH; Lee AC; Chen Q
    Reprod Health; 2016 May; 13(1):58. PubMed ID: 27206481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations of lifetime active and passive smoking with spontaneous abortion, stillbirth and tubal ectopic pregnancy: a cross-sectional analysis of historical data from the Women's Health Initiative.
    Hyland A; Piazza KM; Hovey KM; Ockene JK; Andrews CA; Rivard C; Wactawski-Wende J
    Tob Control; 2015 Jul; 24(4):328-35. PubMed ID: 24572626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombocytopenia: case definition and guidelines for collection, analysis, and presentation of immunization safety data.
    Wise RP; Bonhoeffer J; Beeler J; Donato H; Downie P; Matthews D; Pool V; Riise-Bergsaker M; Tapiainen T; Varricchio F;
    Vaccine; 2007 Aug; 25(31):5717-24. PubMed ID: 17493712
    [No Abstract]   [Full Text] [Related]  

  • 27. Progressive vaccinia as an adverse event following exposure to vaccinia virus: case definition and guidelines of data collection, analysis, and presentation of immunization safety data.
    Nell P; Kohl KS; Graham PL; LaRussa PS; Marcy SM; Fulginiti VA; Martin B; McMahon A; Norton SA; Trolin I;
    Vaccine; 2007 Aug; 25(31):5735-44. PubMed ID: 17540484
    [No Abstract]   [Full Text] [Related]  

  • 28. Generalized vaccinia as an adverse event following exposure to vaccinia virus: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    Beigel J; Kohl KS; Brinley F; Graham PL; Khuri-Bulos N; LaRussa PS; Nell P; Norton S; Stoltman G; Tebaa A; Warschaw K;
    Vaccine; 2007 Aug; 25(31):5745-53. PubMed ID: 17537552
    [No Abstract]   [Full Text] [Related]  

  • 29. Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation.
    Marcy SM; Kohl KS; Dagan R; Nalin D; Blum M; Jones MC; Hansen J; Labadie J; Lee L; Martin BL; O'Brien K; Rothstein E; Vermeer P;
    Vaccine; 2004 Jan; 22(5-6):551-6. PubMed ID: 14741143
    [No Abstract]   [Full Text] [Related]  

  • 30. Inadvertent inoculation as an adverse event following exposure to vaccinia virus: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    Wenger P; Oleske JM; Kohl KS; Fisher MC; Brien JH; Graham PL; LaRussa PS; Lipton S; Tierney B;
    Vaccine; 2007 Aug; 25(31):5754-62. PubMed ID: 17537553
    [No Abstract]   [Full Text] [Related]  

  • 31. Eczema vaccinatum as an adverse event following exposure to vaccinia virus: case definition & guidelines of data collection, analysis, and presentation of immunization safety data.
    Nell P; Kohl KS; Graham PL; LaRussa PS; Marcy SM; Fulginiti VA; Martin B; Trolin I; Norton SA; Neff JM;
    Vaccine; 2007 Aug; 25(31):5725-34. PubMed ID: 17532547
    [No Abstract]   [Full Text] [Related]  

  • 32. Abscess at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.
    Kohl KS; Ball L; Gidudu J; Hammer SJ; Halperin S; Heath P; Hennig R; Labadie J; Rothstein E; Schuind A; Varricchio F; Walop W;
    Vaccine; 2007 Aug; 25(31):5821-38. PubMed ID: 17540485
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased risk of miscarriage and ectopic pregnancy among women with irritable bowel syndrome.
    Khashan AS; Quigley EM; McNamee R; McCarthy FP; Shanahan F; Kenny LC
    Clin Gastroenterol Hepatol; 2012 Aug; 10(8):902-9. PubMed ID: 22373726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellulitis at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.
    Halperin S; Kohl KS; Gidudu J; Ball L; Hammer SJ; Heath P; Hennig R; Labadie J; Rothstein E; Schuind A; Varricchio F; Walop W;
    Vaccine; 2007 Aug; 25(31):5803-20. PubMed ID: 17548135
    [No Abstract]   [Full Text] [Related]  

  • 35. Fatigue: case definition and guidelines for collection, analysis, and presentation of immunization safety data.
    Jones JF; Kohl KS; Ahmadipour N; Bleijenberg G; Buchwald D; Evengard B; Jason LA; Klimas NG; Lloyd A; McCleary K; Oleske JM; White PD;
    Vaccine; 2007 Aug; 25(31):5685-96. PubMed ID: 17400340
    [No Abstract]   [Full Text] [Related]  

  • 36. Maternal age and fetal loss: population based register linkage study.
    Nybo Andersen AM; Wohlfahrt J; Christens P; Olsen J; Melbye M
    BMJ; 2000 Jun; 320(7251):1708-12. PubMed ID: 10864550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data.
    Kohl KS; Walop W; Gidudu J; Ball L; Halperin S; Hammer SJ; Heath P; Varricchio F; Rothstein E; Schuind A; Hennig R;
    Vaccine; 2007 Aug; 25(31):5858-74. PubMed ID: 17548132
    [No Abstract]   [Full Text] [Related]  

  • 38. Induration at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.
    Kohl KS; Walop W; Gidudu J; Ball L; Halperin S; Hammer SJ; Heath P; Hennig R; Rothstein E; Schuind A; Varricchio F;
    Vaccine; 2007 Aug; 25(31):5839-57. PubMed ID: 17553602
    [No Abstract]   [Full Text] [Related]  

  • 39. Rash including mucosal involvement: case definition and guidelines for collection, analysis, and presentation of immunization safety data.
    Beigel J; Kohl KS; Khuri-Bulos N; Bravo L; Nell P; Marcy SM; Warschaw K; Ong-Lim A; Poerschke G; Weston W; Lindstrom JA; Stoltman G; Maurer T;
    Vaccine; 2007 Aug; 25(31):5697-706. PubMed ID: 17403561
    [No Abstract]   [Full Text] [Related]  

  • 40. Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation.
    Bonhoeffer J; Menkes J; Gold MS; de Souza-Brito G; Fisher MC; Halsey N; Vermeer P;
    Vaccine; 2004 Jan; 22(5-6):557-62. PubMed ID: 14741144
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.